Jazz Pharmaceuticals

Roche nabs expanded FDA approval for Ziihera diagnostic

Roche has been given an extended clearance by the FDA for its tests that can find patients eligible to use Jazz Pharmaceuticals’ oncology med Ziihera.

Ben Adams Aug 27, 2026 8:00am

Jazz pays $820M to add epilepsy-focused Actio to its orchestra

Aug 10, 2026 10:40am

Jazz, AbCellera strike TCE discovery and development deal

Jun 17, 2026 7:00am

Takeda inks $1.7B AI discovery deal with Iambic Therapeutics

Feb 9, 2026 8:00am

Paragliding near Tu Le valley with landscape with green and yellow rice fields and blue cloudy sky North- Vietnam

Former Roche oncology head turns to Tubulis—Chutes & Ladders

Jan 9, 2026 8:30am

Jazz pays Saniona $42.5M to add prospect to epilepsy ensemble

Aug 20, 2025 9:13am